February 2, 2024 06:30 AM ESTUpdated February 3, 05:45 AM
People
Peer Review

Ivan Che­ung's post-Ei­sai life takes hold at Next­Point Ther­a­peu­tics; Sanofi, Take­da an­nounce CFO ex­its

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Kyle LaHucik

Senior Reporter

Ivan Che­ung, who led Ei­sai’s US busi­ness and was a cen­tral fig­ure in the biotech’s Alzheimer’s work, has stepped in­to the CEO po­si­tion at a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times